Since the 50-mg dose of safinamide can almost inhibit MAO-B (47), the efficacy of the 100-mg dose in the subgroup with baseline depression may be explained instead by the non-dopaminergic action of safinamide. This evidence concerns the gene MAOB and depressive disorder.